Viola Heinzelmann
Viola Heinzelmann
Professor of Gynecology and Obstetrics, University of Basel
Verified email at usb.ch
Title
Cited by
Cited by
Year
Neutrophils escort circulating tumour cells to enable cell cycle progression
BM Szczerba, F Castro-Giner, M Vetter, I Krol, S Gkountela, J Landin, ...
Nature 566 (7745), 553-557, 2019
3492019
Circulating tumor cell clustering shapes DNA methylation to enable metastasis seeding
S Gkountela, F Castro-Giner, BM Szczerba, M Vetter, J Landin, R Scherrer, ...
Cell 176 (1-2), 98-112. e14, 2019
3162019
ESMO–ESGO consensus conference recommendations on ovarian cancer: pathology and molecular biology, early and advanced stages, borderline tumours and recurrent disease
N Colombo, C Sessa, A Du Bois, J Ledermann, WG McCluggage, ...
Annals of Oncology 30 (5), 672-705, 2019
2692019
Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer
VA Heinzelmann-Schwarz, M Gardiner-Garden, SM Henshall, J Scurry, ...
Clinical Cancer Research 10 (13), 4427-4436, 2004
2342004
No benefit from combining HE4 and CA125 as ovarian tumor markers in a clinical setting
F Jacob, M Meier, R Caduff, D Goldstein, T Pochechueva, N Hacker, ...
Gynecologic oncology 121 (3), 487-491, 2011
2032011
Careful selection of reference genes is required for reliable performance of RT-qPCR in human normal and cancer cell lines
F Jacob, R Guertler, S Naim, S Nixdorf, A Fedier, NF Hacker, ...
PloS one 8 (3), e59180, 2013
1822013
Photodynamic therapy of vulvar and vaginal condyloma and intraepithelial neoplasia using topically applied 5‐aminolevulinic acid
MK Fehr, R Hornung, A Degen, VA Schwarz, D Fink, U Haller, P Wyss
Lasers in Surgery and Medicine: The Official Journal of the American Society …, 2002
1712002
The effect of loss of Brca1 on the sensitivity to anticancer agents in p53-deficient cells
A Fedier, RA Steiner, VA Schwarz, L Lenherr, U Haller, D Fink
International journal of oncology 22 (5), 1169-1173, 2003
1602003
Protein significance analysis in selected reaction monitoring (SRM) measurements
CY Chang, P Picotti, R Hüttenhain, V Heinzelmann-Schwarz, M Jovanovic, ...
Molecular & Cellular Proteomics 11 (4), M111. 014662, 2012
1462012
Resistance to topoisomerase poisons due to loss of DNA mismatch repair
A Fedier, VA Schwarz, H Walt, RD Carpini, U Haller, D Fink
International journal of cancer 93 (4), 571-576, 2001
1452001
Specific glycosylation of membrane proteins in epithelial ovarian cancer cell lines: glycan structures reflect gene expression and DNA methylation status
M Anugraham, F Jacob, S Nixdorf, AV Everest-Dass, ...
Molecular & Cellular Proteomics 13 (9), 2213-2232, 2014
1212014
Photodynamic therapy of vulvar intraepithelial neoplasia III using topically applied 5-aminolevulinic acid
MK Fehr, R Hornung, VA Schwarz, R Simeon, U Haller, P Wyss
Gynecologic oncology 80 (1), 62-66, 2001
1202001
Photodynamic therapy of locoregional breast cancer recurrences using a chlorin‐type photosensitizer
P Wyss, V Schwarz, D Dobler‐Girdziunaite, R Hornung, H Walt, A Degen, ...
International journal of cancer 93 (5), 720-724, 2001
1082001
A distinct molecular profile associated with mucinous epithelial ovarian cancer
VA Heinzelmann-Schwarz, M Gardiner-Garden, SM Henshall, JP Scurry, ...
British journal of cancer 94 (6), 904-913, 2006
1052006
Microtubule-depolymerizing agents used in antibody–drug conjugates induce antitumor immunity by stimulation of dendritic cells
P Müller, K Martin, S Theurich, J Schreiner, S Savic, G Terszowski, ...
Cancer immunology research 2 (8), 741-755, 2014
952014
Self-associated molecular patterns mediate cancer immune evasion by engaging Siglecs on T cells
MA Stanczak, SS Siddiqui, MP Trefny, DS Thommen, KF Boligan, ...
The Journal of clinical investigation 128 (11), 4912-4923, 2018
942018
The Wnt gatekeeper SFRP4 modulates EMT, cell migration and downstream Wnt signalling in serous ovarian cancer cells
CE Ford, E Jary, SSQ Ma, S Nixdorf, VA Heinzelmann-Schwarz, RL Ward
PloS one 8 (1), e54362, 2013
912013
LRP1B deletion in high-grade serous ovarian cancers is associated with acquired chemotherapy resistance to liposomal doxorubicin
PA Cowin, J George, S Fereday, E Loehrer, P Van Loo, C Cullinane, ...
Cancer research 72 (16), 4060-4073, 2012
892012
URI is an oncogene amplified in ovarian cancer cells and is required for their survival
JP Theurillat, SC Metzler, N Henzi, N Djouder, M Helbling, ...
Cancer cell 19 (3), 317-332, 2011
802011
Tumor-targeted 4-1BB agonists for combination with T cell bispecific antibodies as off-the-shelf therapy
C Claus, C Ferrara, W Xu, J Sam, S Lang, F Uhlenbrock, R Albrecht, ...
Science translational medicine 11 (496), 2019
772019
The system can't perform the operation now. Try again later.
Articles 1–20